• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡啶 - 喹啉和联喹啉基钌 - 甲基苯配合物作为转移氢化研究的高效催化剂:合成与结构表征

Pyridine-Quinoline and Biquinoline-Based Ruthenium -Cymene Complexes as Efficient Catalysts for Transfer Hydrogenation Studies: Synthesis and Structural Characterization.

作者信息

Zacharopoulos Nikolaos, Schnakenburg Gregor, Panagopoulou Eleni I, Thomaidis Nikolaos S, Philippopoulos Athanassios I

机构信息

Laboratory of Inorganic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.

Institut für Anorganische Chemie, Rheinische Friedrich-Wilhelms-Universität Bonn, Gerhard-Domagk-Straße 1, D-53121 Bonn, Germany.

出版信息

Molecules. 2025 Jul 11;30(14):2945. doi: 10.3390/molecules30142945.

DOI:10.3390/molecules30142945
PMID:40733211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12300421/
Abstract

Searching for new and efficient transfer hydrogenation catalysts, a series of new organometallic ruthenium(II)-arene complexes of the formulae [Ru(η--cymene)(L)Cl][PF] (-) and [Ru(η--cymene)(L)Cl][Ru(η--cymene)Cl] (-) were synthesized and fully characterized. These were prepared from the reaction of pyridine-quinoline and biquinoline-based ligands (L) with [Ru(η--cymene)(μ-Cl)Cl], in 1:2 and 1:1, metal (M) to ligand (L) molar ratios. Characterization includes a combination of spectroscopic methods (FT-IR, UV-Vis, multi nuclear NMR), elemental analysis and single-crystal X-ray crystallography. The pyridine-quinoline organic entities encountered, were prepared in high yield either via the thermal decarboxylation of the carboxylic acid congeners, namely 2,2'-pyridyl-quinoline-4-carboxylic acid (), 8-methyl-2,2'-pyridyl-quinoline-4-carboxylic acid (), 6'-methyl-2,2'-pyridyl-quinoline-4-carboxylic acid () and 8,6'-dimethyl-2,2'-pyridyl-quinoline-4-carboxylic acid (), affording the desired ligands , and , or by the classical Friedländer condensation, to yield 4,6'-dimethyl-2,2'-pyridyl-quinoline () and 4-methyl-2,2'-pyridyl-quinoline (), respectively. The solid-state structures of complexes -, and were determined showing a distorted octahedral coordination geometry. The unit cell of contains two independent molecules (Ru-), (Ru'-) in a 1:1 ratio, due to a slight rotation of the arene ring. All complexes catalyze the transfer hydrogenation of acetophenone, using 2-propanol as a hydrogen donor in the presence of KOPr. Among them, complexes and bearing methyl groups at the 8 and 4 position of the quinoline moiety, convert acetophenone to 1-phenylethanol quantitatively, within approximately 10 min with final TOFs of 1600 h. The catalytic performance of complexes -, towards the transfer hydrogenation of -substituted acetophenone derivatives and benzophenone, ranges from moderate to excellent. An inner-sphere mechanism has been suggested based on the detection of ruthenium(II) hydride species.

摘要

为寻找新型高效的转移氢化催化剂,合成并全面表征了一系列通式为[Ru(η⁶ - 对异丙基苯)(L)Cl][PF₆]⁻和[Ru(η⁶ - 对异丙基苯)(L)Cl][Ru(η⁶ - 对异丙基苯)Cl]⁻的新型有机金属钌(II)-芳烃配合物。这些配合物由吡啶 - 喹啉和联喹啉基配体(L)与[Ru(η⁶ - 对异丙基苯)(μ - Cl)Cl]按金属(M)与配体(L)的摩尔比1:2和1:1反应制备而成。表征方法包括多种光谱方法(傅里叶变换红外光谱、紫外 - 可见光谱、多核核磁共振)、元素分析和单晶X射线晶体学。所遇到的吡啶 - 喹啉有机实体,通过羧酸同系物的热脱羧反应,即2,2'-吡啶基 - 喹啉 - 4 - 羧酸、8 - 甲基 - 2,2'-吡啶基 - 喹啉 - 4 - 羧酸、6'-甲基 - 2,2'-吡啶基 - 喹啉 - 4 - 羧酸和8,6'-二甲基 - 2,2'-吡啶基 - 喹啉 - 4 - 羧酸,以高产率制备得到所需配体,或者通过经典的Friedländer缩合反应,分别得到4,6'-二甲基 - 2,2'-吡啶基 - 喹啉和4 - 甲基 - 2,2'-吡啶基 - 喹啉。配合物 - 、 和 的固态结构经测定显示出扭曲的八面体配位几何构型。 的晶胞中由于芳烃环的轻微旋转,包含两个以1:1比例的独立分子(Ru - )、(Ru'- )。所有配合物在KOPr存在下,以2 - 丙醇作为氢供体催化苯乙酮的转移氢化反应。其中,在喹啉部分的8位和4位带有甲基的配合物 和 ,在约10分钟内将苯乙酮定量转化为1 - 苯乙醇,最终的转化频率为1600 h⁻¹。配合物 - 对α - 取代苯乙酮衍生物和二苯甲酮的转移氢化反应的催化性能从中等至优异不等。基于氢化钌(II)物种的检测提出了一种内球机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/1fb3c44f07b7/molecules-30-02945-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/f9a0d076c078/molecules-30-02945-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/89a6dc13094c/molecules-30-02945-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/b08153216bca/molecules-30-02945-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/c4faaf8eb2c8/molecules-30-02945-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/8002e91d3ac4/molecules-30-02945-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/48b3b2b394e1/molecules-30-02945-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/1df09fe65a5f/molecules-30-02945-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/3fd79898ce8c/molecules-30-02945-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/1cb7c95a4a0d/molecules-30-02945-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/e64381c63af3/molecules-30-02945-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/44b165aaedb5/molecules-30-02945-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/1fb3c44f07b7/molecules-30-02945-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/f9a0d076c078/molecules-30-02945-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/89a6dc13094c/molecules-30-02945-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/b08153216bca/molecules-30-02945-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/c4faaf8eb2c8/molecules-30-02945-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/8002e91d3ac4/molecules-30-02945-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/48b3b2b394e1/molecules-30-02945-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/1df09fe65a5f/molecules-30-02945-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/3fd79898ce8c/molecules-30-02945-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/1cb7c95a4a0d/molecules-30-02945-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/e64381c63af3/molecules-30-02945-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/44b165aaedb5/molecules-30-02945-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/12300421/1fb3c44f07b7/molecules-30-02945-g009.jpg

相似文献

1
Pyridine-Quinoline and Biquinoline-Based Ruthenium -Cymene Complexes as Efficient Catalysts for Transfer Hydrogenation Studies: Synthesis and Structural Characterization.吡啶 - 喹啉和联喹啉基钌 - 甲基苯配合物作为转移氢化研究的高效催化剂:合成与结构表征
Molecules. 2025 Jul 11;30(14):2945. doi: 10.3390/molecules30142945.
2
Ruthenium -Cymene Complexes Incorporating Substituted Pyridine-Quinoline-Based Ligands: Synthesis, Characterization, and Cytotoxic Properties.钌-苎烯配合物,引入取代吡啶-喹啉基配体:合成、表征和细胞毒性性质。
Molecules. 2024 Jul 6;29(13):3215. doi: 10.3390/molecules29133215.
3
Sterically demanding pyridine-quinoline anchoring ligands as building blocks for copper(I)-based dye-sensitized solar cell (DSSC) complexes.空间位阻较大的吡啶 - 喹啉锚定配体作为基于铜(I)的染料敏化太阳能电池(DSSC)配合物的构建单元。
Dalton Trans. 2022 Oct 11;51(39):15049-15066. doi: 10.1039/d2dt02382b.
4
Enhanced Cytotoxicity of Half-Sandwich Ruthenium(II) Complex Containing -Substituted Salicyllimidazo[1,5-]pyridine toward Hormone-Independent Triple-Negative Breast Cancer Cells.含β-取代水杨酰咪唑并[1,5-a]吡啶的半夹心钌(II)配合物对激素非依赖性三阴性乳腺癌细胞的细胞毒性增强
Inorg Chem. 2025 Jul 21;64(28):14073-14090. doi: 10.1021/acs.inorgchem.5c00090. Epub 2025 Jul 9.
5
Coordination of Ru(II)-Arene Fragments to Dipyridophenazine Ligands Leads to the Modulation of Their In Vitro and In Vivo Anticancer Activity.钌(II)-芳基片段与二吡啶并吩嗪配体的协调导致其体外和体内抗癌活性的调节。
Inorg Chem. 2023 May 29;62(21):8188-8199. doi: 10.1021/acs.inorgchem.3c00570. Epub 2023 May 18.
6
Organometallic Half-Sandwich Complexes of 1,10-Phenanthroline Derivatives with Improved Solubility, Albumin-Binding, and Nanoformulation Potential Targeting Drug Resistance in Cancer.具有改善的溶解性、白蛋白结合能力及纳米制剂潜力的1,10-菲咯啉衍生物的有机金属半夹心配合物靶向癌症耐药性
Inorg Chem. 2025 Jul 28;64(29):14914-14932. doi: 10.1021/acs.inorgchem.5c01556. Epub 2025 Jul 11.
7
From metallodrug design to halochromic nanocarrier delivery: revitalizing the anticancer efficacy and biocompatibility of cyclometalated Ru(II) complex.从金属药物设计到变色纳米载体递送:重振环金属化钌(II)配合物的抗癌功效和生物相容性
J Mater Chem B. 2025 Jul 2;13(26):7714-7727. doi: 10.1039/d4tb02559h.
8
Synthesis, characterization, and biological activity of cationic ruthenium-arene complexes with sulfur ligands.含硫配体的阳离子钌-芳环配合物的合成、表征及生物活性
J Biol Inorg Chem. 2024 Jun;29(4):441-454. doi: 10.1007/s00775-024-02052-2. Epub 2024 May 16.
9
Synthesis and structural characterization of ruthenium(II) hydrido carbonyl triphenylphosphine α-diimine complexes with derivatives of 2,2'-bipyridine.钌(II)氢羰基三苯基膦α-二亚胺配合物与2,2'-联吡啶衍生物的合成及结构表征
Acta Crystallogr C Struct Chem. 2025 Jul 1;81(Pt 7):397-407. doi: 10.1107/S2053229625004619. Epub 2025 Jun 9.
10
Productive Homogeneous Hydrogenation of Fatty Esters with Carboxylate SNS Ruthenium Catalysts.使用羧酸盐SNS钌催化剂对脂肪酸酯进行高效均相氢化反应。
Chemistry. 2025 Aug 7;31(44):e202501898. doi: 10.1002/chem.202501898. Epub 2025 Jul 16.

本文引用的文献

1
Ruthenium -Cymene Complexes Incorporating Substituted Pyridine-Quinoline-Based Ligands: Synthesis, Characterization, and Cytotoxic Properties.钌-苎烯配合物,引入取代吡啶-喹啉基配体:合成、表征和细胞毒性性质。
Molecules. 2024 Jul 6;29(13):3215. doi: 10.3390/molecules29133215.
2
Exploring Hydrogen Sources in Catalytic Transfer Hydrogenation: A Review of Unsaturated Compound Reduction.探索催化转移氢化中的氢源:不饱和化合物还原综述
Molecules. 2023 Nov 11;28(22):7541. doi: 10.3390/molecules28227541.
3
Recent advances of Cp*Ir complexes for transfer hydrogenation: focus on formic acid/formate as hydrogen donors.
用于转移氢化的Cp*Ir配合物的最新进展:聚焦于甲酸/甲酸盐作为氢供体
Org Biomol Chem. 2023 Sep 27;21(37):7484-7497. doi: 10.1039/d3ob01034a.
4
Ruthenium on phosphorous-modified alumina as an effective and stable catalyst for catalytic transfer hydrogenation of furfural.负载在磷改性氧化铝上的钌作为糠醛催化转移加氢的有效且稳定的催化剂。
RSC Adv. 2020 Mar 20;10(19):11507-11516. doi: 10.1039/d0ra00415d. eCollection 2020 Mar 16.
5
Simple synthesis of [Ru(CO)(NHC)(-cymene)] complexes and their use in transfer hydrogenation catalysis.[Ru(CO)(NHC)(对异丙基苯)]配合物的简易合成及其在转移氢化催化中的应用
Dalton Trans. 2021 Sep 28;50(37):13012-13019. doi: 10.1039/d1dt02098f.
6
Transfer hydrogenation catalysis in cells.细胞中的转移氢化催化作用。
RSC Chem Biol. 2020 Nov 5;2(1):12-29. doi: 10.1039/d0cb00150c. eCollection 2021 Feb 1.
7
Arene-Ruthenium(II) Complexes Containing 11-Indeno[1,2-]quinoxalin-11-one Derivatives and Tryptanthrin-6-oxime: Synthesis, Characterization, Cytotoxicity, and Catalytic Transfer Hydrogenation of Aryl Ketones.含11-茚并[1,2 -]喹喔啉-11-酮衍生物和色胺酮-6-肟的芳烃钌(II)配合物:芳基酮的合成、表征、细胞毒性及催化转移氢化反应
ACS Omega. 2020 May 7;5(19):11167-11179. doi: 10.1021/acsomega.0c01204. eCollection 2020 May 19.
8
Enantioselective synthesis of tunable chiral pyridine-aminophosphine ligands and their applications in asymmetric hydrogenation.手性吡啶-胺膦配体的对映选择性合成及其在手性氢化反应中的应用。
Org Biomol Chem. 2019 May 28;17(20):5099-5105. doi: 10.1039/c9ob00770a. Epub 2019 May 9.
9
Metal-ligand cooperation.金属-配体协同作用。
Angew Chem Int Ed Engl. 2015 Oct 12;54(42):12236-73. doi: 10.1002/anie.201503873. Epub 2015 Sep 7.
10
The golden age of transfer hydrogenation.转移氢化的黄金时代。
Chem Rev. 2015 Jul 8;115(13):6621-86. doi: 10.1021/acs.chemrev.5b00203. Epub 2015 Jun 10.